Blood Transfusion Devices Market (By Product: Autotransfusion, Systems and Consumables & Accessories; By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, Others; By End Use: Hospitals, Specialty Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Blood Transfusion Devices Market
5.1. COVID-19 Landscape: Blood Transfusion Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Blood Transfusion Devices Market, By Product
8.1. Blood Transfusion Devices Market, by Product, 2023-2032
8.1.1 Autotransfusion
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Systems and Consumables & Accessories
8.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Blood Transfusion Devices Market, By Application
9.1. Blood Transfusion Devices Market, by Application, 2023-2032
9.1.1. Cardiovascular Surgeries
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Orthopedic Surgeries
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Neurological Surgeries
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Obstetrics & Gynecological Surgeries
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Blood Transfusion Devices Market, By End Use
10.1. Blood Transfusion Devices Market, by End Use, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Specialty Clinics
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Blood Transfusion Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2032)
11.1.2. Market Revenue and Forecast, by Application (2021-2032)
11.1.3. Market Revenue and Forecast, by End Use (2021-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.1.4.3. Market Revenue and Forecast, by End Use (2021-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.1.5.3. Market Revenue and Forecast, by End Use (2021-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.3. Market Revenue and Forecast, by End Use (2021-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.4.3. Market Revenue and Forecast, by End Use (2021-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.5.3. Market Revenue and Forecast, by End Use (2021-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.6.3. Market Revenue and Forecast, by End Use (2021-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.7.3. Market Revenue and Forecast, by End Use (2021-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.3. Market Revenue and Forecast, by End Use (2021-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.4.3. Market Revenue and Forecast, by End Use (2021-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.5.3. Market Revenue and Forecast, by End Use (2021-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.6.3. Market Revenue and Forecast, by End Use (2021-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.7.3. Market Revenue and Forecast, by End Use (2021-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.3. Market Revenue and Forecast, by End Use (2021-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.4.3. Market Revenue and Forecast, by End Use (2021-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.5.3. Market Revenue and Forecast, by End Use (2021-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.6.3. Market Revenue and Forecast, by End Use (2021-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.7.3. Market Revenue and Forecast, by End Use (2021-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.5.3. Market Revenue and Forecast, by End Use (2021-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.5.4.3. Market Revenue and Forecast, by End Use (2021-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.5.5.3. Market Revenue and Forecast, by End Use (2021-2032)
Chapter 12. Company Profiles
12.1. Immucor, Inc. (U.S.)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BD (U.S.)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. B. Braun Melsungen AG (Germany)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Terumo Corporation (Japan)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Grifols, S.A. (Spain)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Fresenius SE & Co. KGaA (Germany)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Haemonetics Corporation (U.S.)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Teleflex Incorporated (U.S.)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Redax (U.S.)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Medtronic (Ireland)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample